INTRODUCTION: After the introduction of L-dopa the mortality rate in Parkinson's disease (PD) patients has changed, but is still higher than in the background population. MATERIAL & METHODS: Mortality, age at death and cause of death in a group of PD patients compared with the background population were studied. The diagnosis on the death certificate were registered. The material consisted of 458 patients who in a period 1.4.1973-31.10.1991 were registered as having PD. RESULTS: Death in the period amounted to 253 patients. Median age of death was 77.29 years for men and 79.11 years for women. In the background population the median age at death was 80.69 years for men and 84.37 years for women. The SMR for men was 1.92 and for women 2.47. Infections, in particular lung infections, and heart diseases were the most common causes of death. Seventy percent of the death certificates had PD as a diagnosis. CONCLUSION: It is likely that several factors can influence the changed mortality of PD: more effective treatment, changing diagnostic practice, and inter-disease competition.
INTRODUCTION: After the introduction of L-dopa the mortality rate in Parkinson's disease (PD) patients has changed, but is still higher than in the background population. MATERIAL & METHODS:Mortality, age at death and cause of death in a group of PDpatients compared with the background population were studied. The diagnosis on the death certificate were registered. The material consisted of 458 patients who in a period 1.4.1973-31.10.1991 were registered as having PD. RESULTS:Death in the period amounted to 253 patients. Median age of death was 77.29 years for men and 79.11 years for women. In the background population the median age at death was 80.69 years for men and 84.37 years for women. The SMR for men was 1.92 and for women 2.47. Infections, in particular lung infections, and heart diseases were the most common causes of death. Seventy percent of the death certificates had PD as a diagnosis. CONCLUSION: It is likely that several factors can influence the changed mortality of PD: more effective treatment, changing diagnostic practice, and inter-disease competition.
Authors: M A Hely; J G Morris; R Traficante; W G Reid; D J O'Sullivan; P M Williamson Journal: J Neurol Neurosurg Psychiatry Date: 1999-09 Impact factor: 10.154
Authors: Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag Journal: J Neurol Neurosurg Psychiatry Date: 2007-03-30 Impact factor: 10.154
Authors: Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke Journal: JAMA Neurol Date: 2017-07-01 Impact factor: 18.302
Authors: Matthew Benskey; Bahareh Behrouz; Johan Sunryd; Samuel S Pappas; Seung-Hoon Baek; Marianne Huebner; Keith J Lookingland; John L Goudreau Journal: Neurotoxicology Date: 2012-02-09 Impact factor: 4.294
Authors: Marina Simeonova; Frank de Vries; Sander Pouwels; Johanna H M Driessen; Hubert G M Leufkens; Suzanne M Cadarette; Andrea M Burden Journal: Br J Clin Pharmacol Date: 2018-08-09 Impact factor: 4.335
Authors: Michael J Aminoff; Chad W Christine; Joseph H Friedman; Kelvin L Chou; Kelly E Lyons; Rajesh Pahwa; Bastian R Bloem; Sotirios A Parashos; Catherine C Price; Irene A Malaty; Robert Iansek; Ivan Bodis-Wollner; Oksana Suchowersky; Wolfgang H Oertel; Jorge Zamudio; Joyce Oberdorf; Peter Schmidt; Michael S Okun Journal: Parkinsonism Relat Disord Date: 2010-12-14 Impact factor: 4.891
Authors: Liancai Mu; Stanislaw Sobotka; Jingming Chen; Hungxi Su; Ira Sanders; Themba Nyirenda; Charles H Adler; Holly A Shill; John N Caviness; Johan E Samanta; Lucia I Sue; Thomas G Beach Journal: J Neuropathol Exp Neurol Date: 2013-07 Impact factor: 3.685
Authors: Roxann Diez Gross; Charles W Atwood; Sheryl B Ross; Kimberly A Eichhorn; Joan W Olszewski; Patrick J Doyle Journal: Dysphagia Date: 2007-11-20 Impact factor: 3.438